Comprehensive Metabolic Panel (CMP) Testing Market By Disease: (Kidney Disease, Liver Disease, Diabetes, Others); By Test Type: (Proteins, Electrolytes, Kidney Tests, Liver Functional Tests, Glucose); By End-Use: (Laboratories, PoC) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 190

The Global Comprehensive Metabolic Panel (CMP) Testing Market size is expected to reach over US$ 18,380 Mn by 2026 and growing at a CAGR of around 7.0% from 2019 to 2026.

The Comprehensive Metabolic Panel (CMP) is a commonly ordered set of 14 tests that give doctor a significant data about the present status of kidneys, electrolyte, liver and acid / base balance as well as blood sugar and blood proteins. Abnormal findings, and in particular abnormal results combinations, may show an issue that needs to be resolved. The CMP is used as a wide screening instrument for diabetes, liver illness, and kidney disease conditions. It is also used for monitoring disease complications or side effects of drugs used for disease treatment. The CMP is regularly provided for a medical or annual physical examination as part of a blood work-up and is gathered by inserting a needle into arm's vein.                              

Market Dynamics

Healthcare awareness among consumers is one of the major factors expected to drive the CMP testing market. Many organizations around the globe are working to increase awareness of illnesses, treatment choices available, and early diagnosis and precautions advantages. The International Diabetes Foundation and the American Diabetes Association, for example, are some of the main organizations that emphasize the pressing need to diagnose and monitor diabetes through multiple awareness campaigns and other advertising methods. Furthermore, over the past few years, the landscape of medical diagnostics has experienced a fundamental shift, driven by the launch of enhanced diagnostic products and biomarker introduction. Recurrence and progression of disease, however, stay high, particularly among geriatric patients. Strong unmet demands pose a main chance in the CMP testing room to create first-class breakthrough diagnostics.

Above pie chart represents the global market share of comprehensive metabolic panel (CMP) testing market, by disease in 2018. The comprehensive metabolic panel market is segmented into disease, test type, end-use and region. The disease segment is bifurcated into kidney disease, liver disease, diabetes, and others. Kidney disease holds near about 42% share of comprehensive metabolic panel (CMP) testing market due to the rising incidence of kidney disease, increasing the amount of biopsy processes and growing demand for fresh chronic disease diagnostic methods. In addition, the accessibility of multiple kidney disease diagnostic tests also affects market growth. It is also anticipated that the growing number of market players will boost market growth during the forecast period. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has indicated that kidney disease is often referred to as a "silent disease" as there are no symptoms in its early phases and may remain undetected.

Report Coverage

The market research study on “Comprehensive Metabolic Panel (CMP) Testing Market – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026, offers a detailed insights on the global comprehensive metabolic panel (CMP) testing market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global comprehensive metabolic panel (CMP) testing market, its product, power source, application, and major geographic regions. The report covers basic development policies and layouts of technology development processes. The comprehensive metabolic panel (CMP) testing market analysis is provided for major regional markets including North America, Europe, Asia-Pacific, Latin America, Middle East & Africa followed by major countries. For each region, the market size for different segments has been covered under the scope of report. The North America includes the global kidney disease market's highest share. The regional market stupendous performance is the consequence of increasing renal disease incidence, especially among geriatric population. In addition, in latest years, the availability of advanced healthcare services in the region has brought great revenue. Regional businesses also stress the need for more studies and development (R&D) and fresh goods to be developed. The growth in financing will also complement these factors, which will assist the region retain its top place throughout the assessment period. Europe has shown optimistic development, supported by high healthcare expenditure and increased awareness of kidney diseases. In addition, increasing public suggestions for CMP and rapidly increasing geriatric population are set to further elevate the market situation in this region. During the forecast period, Asia Pacific is anticipated to grow at the largest CAGR, driven by improved healthcare infrastructure, increased customer awareness, increased disposable income, and general economic development. The market is anticipated to experience fast development in demand for CMP testing in emerging countries such as China, India, and South Korea over the forecast period. The Middle East & Africa is increasing at a steady pace as the incidence of kidney diseases in the region has increased over the previous few years and is also anticipated to increase during forecast period.

The players profiled in the report are Sonic Healthcare, Quest Diagnostics, UNIPATH, Laboratory Corporation of America Holdings (LabCorp), Abbott, SYNLAB International GmbH and among others. The company operated in the market will increase their footprint in the global market by merger and acquisition of local players and focus on the research & development for advance technology.

Market Segmentation

Market By Disease

  • Kidney Disease
  • Liver Disease
  • Diabetes
  • Others

Market By Test Type

  • Proteins
  • Electrolytes
  • Kidney Tests
  • Liver Functional Tests
  • Glucose

Market By End-Use

  • Laboratories
  • PoC

Market By Geography

  • North America
    • US.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa


Related Reports

Healthcare Staffing Market By Service (Travel Nurse, Locum Tenens, Per Diem Nurse, Allied Healthcare) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global healthcare staffing market value is expected to reach around US$ 45.2 Bn by 2026 and growing at a CAGR of around 5.2% over the forecast period 2019 to 2026. Healthcare staffing agencies are the recruitment firms that provide a broad spectrum of healthcare staff ranging from nurse and physician to allied clinician and pharmacists. Healthcare facilities often need assistan

Ambulatory Surgical and Emergency Centers Market By Service Type (Orthopedics, Ophthalmology, Gastroenterology, Plastic Surgery, Pain Management or Spinal Injections, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ambulatory surgical and emergency centers market is expected to grow at a CAGR of 6.2% over the forecast period 2019 to 2026 and market size is poised to reach US$ 203.1 Bn by 2026. Ambulatory surgery and emergency centers are medical care facilities that provide same-day surgery care which also includes consultation and diagnosis. It is a more convenient alternative to hospital based outpatient pro

Ambulatory Health Care Services Market By Type (Primary Care Offices, Medical Specialty, Emergency Departments, Surgical Specialty), By Application (Orthopedics, Ophthalmology, Gastroenterology, Plastic Surgery, Pain Management or Spinal Injections, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ambulatory health care services market size is expected to surpass US$ 4.4 Tn by 2026 and will grow at a noteworthy CAGR of 5.9% over the forecast period 2019 to 2026. Ambulatory service centers (ASC) also referred as outpatient care centers. These are medical care facilities that provide outpatient services such as consultation, diagnosis, treatment, and intervention services. It is a more convenie

Ambulatory EHR Market By Application (Patient Management, Practice Management, E-prescribing, Population Health Management, Referral Management, Health Analytics, Decision Support), By Delivery Mode (Client Server-based, Web-based), By End User Mode (Independent Ambulatory Centers, Hospital-owned Ambulatory Centers) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ambulatory EHR market size is expected to reach US$ 6.8 billion by 2026 and will grow at a CAGR of around 6.0% over the forecast period 2019 to 2026. The digital version of the patient’s record is known as the electronic health records. It includes a wide range of patient’s information such as medical history, ongoing medication, allergies, personal statistics, the status of immunization, demographics, and laborator

Cancer Biomarkers Market By Type (Protein, Genetic, Others), By Technology (Omics Technology, Immunoassay, Imaging Technology, Cytogenetic Testing), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Leukemia, Thyroid gland Cancer, Kidney Cancer, Bladder Cancer, Others), By Application (Diagnosis, Prognosis, Research, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global cancer biomarkers market size is expected to reach around US$ 29.8 Bn by 2026 and will grow at noteworthy CAGR of around 11.9% over the forecast period 2019 to 2026. Cancer biomarker is a substance that helps to indicate the presence of cancer in the body. This substance may be a molecule secreted by a tumor or specific response of the body to a tumor. Genetic, proteomic

4D Printing in Healthcare Market By Component(Equipment, Software & Services, Programmable Materials), By Technology (PolyJet, FDM, Stereolithography, SLS), By Application (Patient Specific Implant, Medical Research Models, Surgical Guides), By End User (Hospitals, Dental Laboratories, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global 4D printing in healthcare market size is expected to reach around US$ 34.1 Mn by 2026 growing at a CAGR of around 29.6% over the forecast period 2019 to 2026. 4D printing is the latest technology in healthcare that is going to revolutionize the artificial organs and prosthetics industry. 4D printing is a product of collaboration work between MIT’s Lab and Stratasys. 4D printing is evolved 3D p

Cart Summary